'Phantom' Motrin Recall Probe Intensifies

A Congressional probe into a "phantom" 2009 recall of Motrin pain relief caplets is causing headaches for the pharmaceutical giant Johnson & Johnson. On Monday afternoon, Johnson & Johnson CEO William Weldon was due to respond to a formal inquiry about the matter from Rep. Edolphus Towns, D-N.Y., chairman of the House Committee on Oversight and Government Reform. Rep. Towns is seeking more details surrounding what he described as a "phantom recall" of Motrin caplets supposedly carried out last...Full Story
Commenting on this article is closed.